Lew Lim
Founder and CEO | Vielight
Toronto, ON, CANADA
Dr. Lew Lim is the founder and CEO of VieLight
Spotlight
Media
Publications:
Documents:
Photos:
Videos:
Audio/Podcasts:
Biography
Dr. Lew Lim is the Founder & CEO of Vielight Inc., and is the inventor of the devices offered by the company. He is a leader in translating the science of photobiomodulation (PBM) into wearable and personal use products, particularly in the field of neurology and neuroscience. Today, he directs much of his energy in the search of a solution for Alzheimer’s disease and other brain diseases using PBM. He is also actively pursuing to realize the potential of PBM to address other medical conditions and to enhance human potential. His education and training comprises of engineering, neuroscience, natural medicine, finance, accountancy and management. He obtained his degrees and diplomas from University of California at Berkeley, University of Sheffield, Quantum University, Duke University and The Institute of Chartered Management Accountants, UK.
Areas of Expertise (7)
Medical Devices
Phototherapy
Start-Ups
Corporate Planning
Entrepreneurship
Photobiomodulation
Light Therapy
Education (5)
Quantum University: DNM, Natural Medicine 2016
Quantum University: Ph.D., Natural Medicine 2016
Trinity School of Natural Health: Doctor of Naturopathy, Natural Medicine 2014
University of California, Berkeley: Graduate Certificate, Engineering 2002
The University of Sheffield: MBA, Finance 1981
Affiliations (5)
- MedicLights Research Inc. : President and Founder
- SPIE, the International Society for Optics and Photonics : Member
- OSA - The Optical Society : Member
- North American Association of Light Therapy : Member
- Mensa International : Member
Links (2)
Languages (2)
- English
- Malay
Media Appearances (5)
How To Blast The Brain With Energy by Using Red Light Therapy Headsets, Laser/LED Treatment For COVID, Instantly Shift the Brain Into A "Bliss" State & More
Ben Greenfield Life online
2023-02-04
Vielight's Lew Lim talks to Ben about how to blast your brain with energy using red light, LED treatment for COVID, and more...
Vielight Inc. introduces Neuro Pro device
Canadian Manufacturing online
2022-03-29
According to Dr. Lew Lim, the Founder and CEO of Vielight Inc., “We intend to delight the owners of the Neuro Pro with the regular release of improvements and the expansion of Neuro Pro functionality.” “We intend to delight the owners of the Neuro Pro with the regular release of improvements and the expansion of Neuro Pro functionality,” said Dr. Lew Lim, founder and CEO of Vielight Inc. in a statement.
Vielight Launches COVID-19 Clinical Trial with Home-Use Device
Yahoo! Finance online
2020-09-01
“We have designed the Vielight RX Plus with specific parameters based on PBM research that are relevant to impacting coronavirus infections. By conducting this study, we seek to prove the hypothesis that the Vielight RX Plus will accelerate recovery and reduce the severity of the viral infection”, said Dr. Lew Lim, Founder and CEO of Vielight Inc. “It’s affordability, comfort and suitability for home-use are important features needed for widespread adoption. We now need to evaluate through this clinical trial, whether it will also be effective.”
Paralysed man, 25, forced to make miraculous recovery alone due to coronavirus lockdown
Daily Mirror online
2020-04-03
Dr Lew Lim, CEO and Founder of Vielight said: “When you deliver near infrared light to an injured brain, it could recover more quickly. We are validating this in a clinical trial at Boston University.”
Neuro RX Gamma headset helps Alzheimer’s patients recover their memories
Tech Explorist online
2020-01-07
“Photobiomodulation introduces the therapeutic effect of light into our brain,” Dr. Lew Lim, the CEO of Vielight and inventor of the device, told The Telegraph. “It triggers the body to restore its natural balance or homeostasis. When we do that, we call upon the body’s innate ability to heal.”
Patents (3)
Self-administrable method, system and apparatus for non-invasive neurostimulation therapy of the brain
13/986,768
2013-06-04
The present invention is a portable non-invasive apparatus, system, and method for performing light therapy or photobiomodulation upon the brain tissues through the nostrils of a living mammalian subject for the medical purpose of stimulating the brain in-vivo. In marked difference to conventionally known therapeutic procedures, the present invention utilizes the intranasal pathway as the point of...
Method and portable system for non-invasive, in-vivo blood irradiation light therapy
8535361
2010-06-16
The present invention is a non-invasive apparatus, system, and method for performing irradiation light therapy upon blood circulating within the nostrils of a living mammalian subject. The merit and medical value of the invention resides in its ability to achieve a reversal of red blood cell aggregation in-vivo without invading the tissues or organs of the living subject—a clinical result which...
Using internet content as a means to establish live social networks by linking internet users to each other who are simultaneously engaged in the same and/or similar content
8117281
2007-11-02
A system and method that uses internet content and/or content metadata as a means to establish social networks. Examples include linking internet users, searchers, viewers and/or listeners of the same and/or similar internet content to each other via a platform that enables any of the following in n-dimensional environments: social networking, communications, sharing, e-commerce, advertising,...
Articles (3)
Modifying resting-state EEG microstates with pulsed near-infrared transcranial photobiomodulation: a randomized sham-controlled crossover study
Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation2021 Objective: Transcranial Photobiomodulation (tPBM) is a novel noninvasive brain stimulation technique that applies near-infrared (NIR) light and influences cortical oscillation. However, the mechanism and extent of its effects are yet to be understood. In this study, we investigated the effect of active vs. sham tPBM on the temporal dynamics of large-scale brain networks using resting-state EEG microstate. Methods: Twenty healthy volunteers received 20 minutes of active or sham tPBM using 810 nm light-emitting diodes (LEDs), pulsed at 40 Hz with 50% duty cycle, delivered transcranially to the default mode network. 10-minute eyes-closed EEG recordings were collected before and after each stimulation session. The artifact-free resting-state data were used for microstate analysis, focusing on the mean duration, frequency of occurrence, and ratio of time coverage. We used the two-step k-mean clustering method to …
Home-use Photobiomodulation Device Treatment Outcomes for COVID-19
medRxiv2022 BACKGROUND There is need for non-pharmaceutical treatments for COVID-19. A home-use photobiomodulation (PBM) device was tested as Treatment in a randomized clinical trial. METHODS 294 patients were randomized with equal allocation to Treatment or Standard of Care (Control). 199 qualified for efficacy analyses. The Treatment group self-treated for 20 minutes twice daily, for the first 5 days, and subsequently once daily for 30 days. A validated respiratory questionnaire was used, and patients were monitored remotely. The primary endpoint was the time-to-recovery (3 consecutive days of no sickness) for general sickness. The Kaplan-Meier method and the Cox Proportional Hazards model were primary methods of analyses.
Near-infrared photobiomodulation of living cells, tubulin, and microtubules in vitro
Frontiers in Medical Technology2022 We report the results of experimental investigations involving photobiomodulation (PBM) of living cells, tubulin, and microtubules in buffer solutions exposed to near-infrared (NIR) light with a wavelength of 810 nm pulsed at a frequency of 10 Hz. In the first group of experiments, we measured changes in the alternating current (AC) ionic conductivity in the 50–100 kHz range of HeLa and U251 cancer cell lines as living cells, exposed to PBM for 60 minutes, and observed increased resistance compared to the control experiments. In the second group of experiments we investigated the stability and polymerization of microtubules under exposure to PBM. The protein buffer solution used was BRB80/PEM. Exposure of TaxolTM-stabilized microtubules (∼ 2 μM tubulin) to the LED at 810 nm, with a power density of 25 mW/cm2 pulsing at 10 Hz for 120 minutes, resulted in gradual disassembly of microtubules observed in fluorescence microscopy images.
Social